The New Standard in Computational Neuroscience

Join Nick Spiller, Venture Principal at Capital Factory, as he chats with Maxwell Dordevic, a trailblazing entrepreneur and CEO and Co-Founder of NeuroX1. Max shares his journey from stem cell research to founding NeuroX1, a company using AI to tackle neurodegenerative diseases.

Max discusses his transition from research to entrepreneurship, the pivotal moment that led to co-founding NeuroX1, and the personal experiences driving his passion. Discover how NeuroX1 employs physics-based simulations and AI to develop new drug molecules, aiming to revolutionize treatments for MS, ALS, and Alzheimer’s.

Learn about NeuroX1’s rapid progress, key milestones, and Max’s advice for entrepreneurs navigating today’s market. This episode offers a glimpse into the future of personalized medicine and the fight against debilitating diseases.

Get the best Austinpreneur updates at www.capitalfactory.com/podcast